Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate'.

× No keyword cloud information.

13 in total

1. Use of tyrosine kinase inhibitors in a patient with Brugada syndrome and chronic myeloid leukemia.

Authors: Nicola Sgherza; Antonella Vita Russo Rossi; Paolo Colonna; Paola Carluccio; Mario Delia; Giorgina Specchia
Journal: Int J Hematol Date: 2013-07-24 Impact factor: 2.490

Review 2. Mechanisms of Cardiovascular Toxicity of BCR-ABL1 Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia.

Authors: Dakota Gustafson; Jason E Fish; Jeffrey H Lipton; Nazanin Aghel
Journal: Curr Hematol Malig Rep Date: 2020-02 Impact factor: 3.952

Review 3. Chronic myelogenous leukemia: treatment and monitoring.

Authors: Nikolas von Bubnoff; Justus Duyster
Journal: Dtsch Arztebl Int Date: 2010-02-19 Impact factor: 5.594

Review 4. Imatinib: a review of its use in the management of gastrointestinal stromal tumours.

Authors: M Asif A Siddiqui; Lesley J Scott
Journal: Drugs Date: 2007 Impact factor: 9.546

Review 5. From Molecular Mechanisms to Clinical Management of Antineoplastic Drug-Induced Cardiovascular Toxicity: A Translational Overview.

Authors: Carlo Gabriele Tocchetti; Christian Cadeddu; Daniela Di Lisi; Saveria Femminò; Rosalinda Madonna; Donato Mele; Ines Monte; Giuseppina Novo; Claudia Penna; Alessia Pepe; Paolo Spallarossa; Gilda Varricchi; Concetta Zito; Pasquale Pagliaro; Giuseppe Mercuro
Journal: Antioxid Redox Signal Date: 2017-05-15 Impact factor: 8.401

6. A dosing/cross-development study of the multikinase inhibitor sorafenib in patients with pulmonary arterial hypertension.

Authors: M Gomberg-Maitland; M L Maitland; R J Barst; L Sugeng; S Coslet; T J Perrino; L Bond; M E Lacouture; S L Archer; M J Ratain
Journal: Clin Pharmacol Ther Date: 2009-12-09 Impact factor: 6.875

Review 7. Imatinib: a review of its use in chronic myeloid leukaemia.

Authors: Marit D Moen; Kate McKeage; Greg L Plosker; M Asif A Siddiqui
Journal: Drugs Date: 2007 Impact factor: 9.546

8. Cardiotoxicity associated with targeted cancer therapies.

Authors: Z I Chen; D I Ai
Journal: Mol Clin Oncol Date: 2016-03-03

Review 9. Cardiovascular toxicities: clues to optimal administration of vascular endothelial growth factor signaling pathway inhibitors.

Authors: Kelly L Snider; Michael L Maitland
Journal: Target Oncol Date: 2009-04-17 Impact factor: 4.493

Review 10. Tyrosine Kinase Inhibitor-Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia.

Authors: Javid J Moslehi; Michael Deininger
Journal: J Clin Oncol Date: 2015-09-14 Impact factor: 44.544